FDA approves first treatment for Erdheim-Chester Disease
On Nov. 6, the U.S. Food and Drug Administration (FDA) expanded approval of Zelboraf (vemurafenib) to treat certain adult patients with Erdheim-Chester Disease. (more…)
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.